<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>3</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art12">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>71118</ArticleID>
            <ArticleDOI>10.1208/aapsj070112</ArticleDOI>
            <ArticleSequenceNumber>12</ArticleSequenceNumber>
            <ArticleTitle Language="En">Role of the breast cancer resistance protein (ABCG2) in drug transport</ArticleTitle>
            <ArticleFirstPage>E118</ArticleFirstPage>
            <ArticleLastPage>E133</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>9</Month>
                <Day>9</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>2</Month>
                <Day>2</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>1</IssueIDStart>
              <IssueIDEnd>1</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Qingcheng</GivenName>
                  <FamilyName>Mao</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(206) 685-0355</Phone>
                  <Fax>(206) 543-3204</Fax>
                  <Email>qmao@ u.washington.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmaceutics, School of Pharmacy</OrgDivision>
                <OrgName>University of Washington</OrgName>
                <OrgAddress>
                  <Postbox>Box 357610</Postbox>
                  <Postcode>98195-7610</Postcode>
                  <City>Seattle</City>
                  <State>WA</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>The 72-kDa breast cancer resistance protein (BCRP) is the second member of the subfamily G of the human ATP binding cassette (ABC) transporter superfamily and thus also designated as ABCG2. Unlike P-glycoprotein and MRP1, which are arranged in 2 repeated halves, BCRP is a half-transporter consisting of only 1 nucleotide binding domain followed by 1 membrane-spanning domain. Current experimental evidence suggests that BCRP may function as a homodimer or homotetramer. Overexpression of BCRP is associated with high levels of resistance to a variety of anticancer agents, including anthracyclines, mitoxantrone, and the camptothecins, by enhancing drug efflux. BCRP expression has been detected in a large number of hematological malignancies and solid tumors, indicating that this transporter may play an important role in clinical drug resistance of cancers. In addition to its role to confer resistance against chemotherapeutic agents, BCRP actively transports structurally diverse organic molecules, conjugated or unconjugated, such as estrone-3-sulfate, 17β-estradiol 17-(β-D-glucuronide), and methotrexate. BCRP is highly expressed in the placental syncytiotrophoblasts, in the apical membrane of the epithelium in the small intestine, in the liver canalicular membrane, and at the luminal surface of the endothelial cells of human brain microvessels. This strategic and substantial tissue localization indicates that BCRP also plays an important role in absorption, distribution, and elimination of drugs that are BCRP substrates. This review summarizes current knowledge of BCRP and its relevance to multidrug resistance and drug disposition.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>BCRP</Keyword>
              <Keyword>ATP-binding cassette</Keyword>
              <Keyword>ABCG2</Keyword>
              <Keyword>transporter</Keyword>
              <Keyword>drug transport</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: May 11, 2005.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_71118.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SV</Initials>
                    <FamilyName>Ambudkar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Kimchi-Sarfaty</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZE</Initials>
                    <FamilyName>Sauna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Gottesman</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">P-glycoprotein: from genomies to mechanism</ArticleTitle>
                  <JournalTitle>Oncogene.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>7468</FirstPage>
                  <LastPage>7485</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14576852</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXotlaju70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.onc.1206948</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomies to mechanism.<Emphasis Type="Italic">Oncogene.</Emphasis> 2003;22:7468–7485.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Haimeur</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Conseil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Deeley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation</ArticleTitle>
                  <JournalTitle>Curr Drug Metab.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>53</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14965249</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvVCisLo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1389200043489199</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.<Emphasis Type="Italic">Curr Drug Metab.</Emphasis> 2004;5:21–53.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LV</Initials>
                    <FamilyName>Abruzzo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">A multidrug resistance transporter from human MCF-7 breast cancer cells</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>95</VolumeID>
                  <FirstPage>15665</FirstPage>
                  <LastPage>15670</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9861027</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhvFeitQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.95.26.15665</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1998;95:15665–15670.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Miyake</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Mickley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone resistant cells: demonstration of homology to ABC transport genes</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>8</FirstPage>
                  <LastPage>13</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9892175</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmsFKqsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miyake K, Mickley L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone resistant cells: demonstration of homology to ABC transport genes.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1999;59:8–13.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Allikmets</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Schriml</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Hutchinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Romano-Spica</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dean</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>5337</FirstPage>
                  <LastPage>5339</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9850061</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXotVSkt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1998;58:5337–5339.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Rocchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Khodjakov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Volk</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun.</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <FirstPage>42</FirstPage>
                  <LastPage>46</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10777678</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXis1agsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2000.2590</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 2000;271:42–46.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Scheffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IF</Initials>
                    <FamilyName>Faneyte</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>3458</FirstPage>
                  <LastPage>3464</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11309308</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjtFSju7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2001;61:3458–3464.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Schinkel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)</ArticleTitle>
                  <JournalTitle>Mol Cancer Ther.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>427</FirstPage>
                  <LastPage>434</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12477055</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjt1yqs7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen JD, Schinkel AH. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2).<Emphasis Type="Italic">Mol Cancer Ther.</Emphasis> 2002;1:427–434.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</ArticleTitle>
                  <JournalTitle>Oncogene.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>7340</FirstPage>
                  <LastPage>7358</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14576842</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.onc.1206938</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXotlajur0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).<Emphasis Type="Italic">Oncogene.</Emphasis> 2003;22:7340–7358.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Bates</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Miyake</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Rao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The role of half-transporters in multidrug resistance</ArticleTitle>
                  <JournalTitle>J Bioenerg Biomembr.</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>503</FirstPage>
                  <LastPage>511</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11804192</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsVyltw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1012879205914</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bates SE, Robey R, Miyake K, Rao K, Ross DD, Litman T. The role of half-transporters in multidrug resistance.<Emphasis Type="Italic">J Bioenerg Biomembr.</Emphasis> 2001;33:503–511.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dean</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Allikmets</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Complete characterization of the human ABC gene family</ArticleTitle>
                  <JournalTitle>J Bioenerg Biomembr.</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>475</FirstPage>
                  <LastPage>479</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11804189</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsVylsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1012823120935</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dean M, Allikmets R. Complete characterization of the human ABC gene family.<Emphasis Type="Italic">J Bioenerg Biomembr.</Emphasis> 2001;33:475–479.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Borst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RO</Initials>
                    <FamilyName>Elferink</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Mammalian ABC transporters in health and disease</ArticleTitle>
                  <JournalTitle>Annu Rev Biochem.</JournalTitle>
                  <VolumeID>71</VolumeID>
                  <FirstPage>537</FirstPage>
                  <LastPage>592</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12045106</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xos1Clt74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.biochem.71.102301.093055</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Borst P, Elferink RO. Mammalian ABC transporters in health and disease.<Emphasis Type="Italic">Annu Rev Biochem.</Emphasis> 2002;71:537–592.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Riordan</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein</ArticleTitle>
                  <JournalTitle>Am J Hum Genet.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1499</FirstPage>
                  <LastPage>1504</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10330337</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltlOgtLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1086/302429</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Riordan JR. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.<Emphasis Type="Italic">Am J Hum Genet.</Emphasis> 1999;64:1499–1504.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Arnell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mantyjarvi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Tuppurainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Andreasson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Dahl</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Stargardt disease: linkage to the ABCR gene region on lp21-p22 in Scandinavian families</ArticleTitle>
                  <JournalTitle>Acta Ophthalmol Scand.</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>649</FirstPage>
                  <LastPage>652</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9881544</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M%2FpsFyksw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1034/j.1600-0420.1998.760602.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Arnell H, Mantyjarvi M, Tuppurainen K, Andreasson S, Dahl N. Stargardt disease: linkage to the ABCR gene region on lp21-p22 in Scandinavian families.<Emphasis Type="Italic">Acta Ophthalmol Scand.</Emphasis> 1998;76:649–652.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kartenbeck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Leuschner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mayer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Keppler</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome</ArticleTitle>
                  <JournalTitle>Hepatology.</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>1061</FirstPage>
                  <LastPage>1066</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8621134</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:BymB3cnltlc%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1053/jhep.1996.v23.pm0008621134</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome.<Emphasis Type="Italic">Hepatology.</Emphasis> 1996;23:1061–1066.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Klucken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Buchler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Orso</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>817</FirstPage>
                  <LastPage>822</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10639163</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXot1anug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.97.2.817</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Klucken J, Buchler C, Orso E, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2000;97:817–822.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Bergmann</FamilyName>
                    <Particle>von</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lutjohann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Hobbs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Selective sterol accumulation in ABCG5/ABCG8-deficient mice</ArticleTitle>
                  <JournalTitle>J Lipid Res.</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>301</FirstPage>
                  <LastPage>307</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14657202</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhslOmt78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1194/jlr.M300377-JLR200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yu L, von Bergmann K, Lutjohann D, Hobbs HH, Cohen JC. Selective sterol accumulation in ABCG5/ABCG8-deficient mice.<Emphasis Type="Italic">J Lipid Res.</Emphasis> 2004;45:301–307.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Graf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WP</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>278</VolumeID>
                  <FirstPage>48275</FirstPage>
                  <LastPage>48282</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14504269</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpt1Gjtrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M310223200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Graf GA, Yu L, Li WP, et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2003;278:48275–48282.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Li-Hawkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Hammer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol</ArticleTitle>
                  <JournalTitle>J Clin Invest.</JournalTitle>
                  <VolumeID>110</VolumeID>
                  <FirstPage>671</FirstPage>
                  <LastPage>680</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12208868</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmslyitrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI200216001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yu L, Li-Hawkins J, Hammer RE, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.<Emphasis Type="Italic">J Clin Invest.</Emphasis> 2002;110:671–680.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bates</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Characterization of oligomeric human half ABC transporter ABCG2/BCRP/MXR/ABCP in plasma membranes</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>279</VolumeID>
                  <FirstPage>19781</FirstPage>
                  <LastPage>19789</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15001581</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjs1Wit7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M310785200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Xu J, Liu Y, Yang Y, Bates S, Zhang JT. Characterization of oligomeric human half ABC transporter ABCG2/BCRP/MXR/ABCP in plasma membranes.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2004;279:19781–19789.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ozvegy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Varadi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Sarkadi</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>277</VolumeID>
                  <FirstPage>47980</FirstPage>
                  <LastPage>47990</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12374800</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xptlehuro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M207857200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ozvegy C, Varadi A, Sarkadi B. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2002;277:47980–47990.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Janvilisri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Venter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Shahi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Reuter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Balakrishnan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HW</Initials>
                    <FamilyName>Veen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Sterol transport by the human breast cancer resistance protein (ABC G2) expressed in Lactococcus lactis</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>278</VolumeID>
                  <FirstPage>20645</FirstPage>
                  <LastPage>20651</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12668685</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkt1Wju7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M301358200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW Sterol transport by the human breast cancer resistance protein (ABC G2) expressed in Lactococcus lactis.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2003;278:20645–20651.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LV</Initials>
                    <FamilyName>Abruzzo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines</ArticleTitle>
                  <JournalTitle>J Natl Cancer Inst.</JournalTitle>
                  <VolumeID>91</VolumeID>
                  <FirstPage>429</FirstPage>
                  <LastPage>433</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10070941</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhvFKitL8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/jnci/91.5.429</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ross DD, Yang W, Abruzzo LV, et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.<Emphasis Type="Italic">J Natl Cancer Inst.</Emphasis> 1999;91:429–433.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Gastelen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Jong</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>4559</FirstPage>
                  <LastPage>4563</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10493507</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmtVKksbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maliepaard M, van Gastelen MA, de Jong LA, et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1999;59:4559–4563.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CH</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Kuo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Volk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Rocchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YC</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol.</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>831</FirstPage>
                  <LastPage>837</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10930538</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXltlWgtL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-2952(00)00396-8</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yang CH, Schneider E, Kuo ML, Volk EL, Rocchi E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2000;60:831–837.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ishii</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Iwahana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Mitsui</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variantsderived from the human lung cancer cell line PC-6</ArticleTitle>
                  <JournalTitle>Anticancer Drugs.</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>353</FirstPage>
                  <LastPage>362</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10912951</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXltVegtLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001813-200006000-00005</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ishii M, Iwahana M, Mitsui I, et al. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variantsderived from the human lung cancer cell line PC-6.<Emphasis Type="Italic">Anticancer Drugs.</Emphasis> 2000;11:353–362.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WY</Initials>
                    <FamilyName>Medina-Perez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nishiyama</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BC rp/ABCP1), in flavopiridol-resistant human breast cancer cells</ArticleTitle>
                  <JournalTitle>Clin Cancer Res.</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>152</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11205902</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXht1Whtrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Robey RW, Medina-Perez WY, Nishiyama K, et al. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BC rp/ABCP1), in flavopiridol-resistant human breast cancer cells.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2001;7:145–152.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RF</Initials>
                    <FamilyName>Brinkhuis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Wijnholds</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Schinkel</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The mouse Berpl/Mxr/Abep gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>4237</FirstPage>
                  <LastPage>4241</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10485464</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlvVSmsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen JD, Brinkhuis RF, Wijnholds J, Schinkel AH. The mouse Berpl/Mxr/Abep gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1999;59:4237–4241.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Eisenblatter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Galla</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A new multidrug resistance protein at the blood-brain barrier</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun.</JournalTitle>
                  <VolumeID>293</VolumeID>
                  <FirstPage>1273</FirstPage>
                  <LastPage>1278</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12054514</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-291X(02)00376-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xks1Ggurk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eisenblatter T, Galla HJ. A new multidrug resistance protein at the blood-brain barrier.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 2002;293:1273–1278.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Eisenblatter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Huwel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Galla</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>971</VolumeID>
                  <FirstPage>221</FirstPage>
                  <LastPage>231</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12706238</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXivFequ7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(03)02401-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eisenblatter T, Huwel S, Galla HJ. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.<Emphasis Type="Italic">Brain Res.</Emphasis> 2003;971:221–231.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ohtsuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Tachikawa</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s)</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>526</FirstPage>
                  <LastPage>536</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15255930</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmsFersb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02537.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hori S, Ohtsuki S, Tachikawa M, et al. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s).<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;90:526–536.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rajagopal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Simon</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Subcellular localization and activity of multidrug resistance proteins</ArticleTitle>
                  <JournalTitle>Mol Biol Cell.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>3389</FirstPage>
                  <LastPage>3399</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12925771</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvFWks7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1091/mbc.E02-11-0704</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rajagopal A, Simon SM. Subcellular localization and activity of multidrug resistance proteins.<Emphasis Type="Italic">Mol Biol Cell.</Emphasis> 2003;14:3389–3399.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Chanda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FP</Initials>
                    <FamilyName>Dicke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Gerlach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Mirski</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>3345</FirstPage>
                  <LastPage>3352</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1675932</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXks1Chs7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cole SP, Chanda ER, Dicke FP, Gerlach JH, Mirski SE. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1991;51:3345–3352.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Aust</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Obrist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Jaeger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium</ArticleTitle>
                  <JournalTitle>Lab Invest.</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <FirstPage>1024</FirstPage>
                  <LastPage>1036</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15146167</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmvF2ksb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/labinvest.3700127</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aust S, Obrist P, Jaeger W, et al. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium.<Emphasis Type="Italic">Lab Invest.</Emphasis> 2004;84:1024–1036.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Brangi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hudson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)</ArticleTitle>
                  <JournalTitle>J Cell Sci.</JournalTitle>
                  <VolumeID>113</VolumeID>
                  <FirstPage>2011</FirstPage>
                  <LastPage>2021</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10806112</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXksVKntrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Litman T, Brangi M, Hudson E, et al. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).<Emphasis Type="Italic">J Cell Sci.</Emphasis> 2000;113:2011–2021.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Honjo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Laar</FamilyName>
                    <Particle>van de</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta.</JournalTitle>
                  <VolumeID>1512</VolumeID>
                  <FirstPage>171</FirstPage>
                  <LastPage>182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11406094</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXkt12itbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0005-2736(01)00308-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Robey RW, Honjo Y, van de Laar A, et al. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).<Emphasis Type="Italic">Biochim Biophys Acta.</Emphasis> 2001;1512:171–182.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Minderman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Suvannasankha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>O'Loughlin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Flow cytometric analysis of breast cancer resistance protein expression and function</ArticleTitle>
                  <JournalTitle>Cytometry.</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>59</FirstPage>
                  <LastPage>65</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12116365</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlt1Cgtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/cyto.10111</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Minderman H, Suvannasankha A, O'Loughlin KL, et al. Flow cytometric analysis of breast cancer resistance protein expression and function.<Emphasis Type="Italic">Cytometry.</Emphasis> 2002;48:59–65.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Rabindran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Greenberger</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>47</FirstPage>
                  <LastPage>50</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10646850</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1ahtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2000;60:47–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Hazlehurst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NE</Initials>
                    <FamilyName>Foley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Gleason-Guzman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>1021</FirstPage>
                  <LastPage>1028</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10070958</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhslemtbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hazlehurst LA, Foley NE, Gleason-Guzman MC, et al. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1999;59:1021–1028.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nakagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KH</Initials>
                    <FamilyName>Dixon</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Reduced intracellular drug accumulation in the abscence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>6175</FirstPage>
                  <LastPage>6181</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1358431</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXjt1KgtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakagawa M, Schneider E, Dixon KH, et al. Reduced intracellular drug accumulation in the abscence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1992;52:6175–6181.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Gastelen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Tohgo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918</ArticleTitle>
                  <JournalTitle>Clin Cancer Res.</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>935</FirstPage>
                  <LastPage>941</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11309344</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjs1elsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maliepaard M, van Gastelen MA, Tohgo A, et al. Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2001;7:935–941.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kawabata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Oka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Shiozawa</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun.</JournalTitle>
                  <VolumeID>280</VolumeID>
                  <FirstPage>1216</FirstPage>
                  <LastPage>1223</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11162657</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXptlCrsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2001.4267</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kawabata S, Oka M, Shiozawa K, et al. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 2001;280:1216–1223.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakatomi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Yoshikawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Oka</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun.</JournalTitle>
                  <VolumeID>288</VolumeID>
                  <FirstPage>827</FirstPage>
                  <LastPage>832</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11688982</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnvFGisLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2001.5850</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakatomi K, Yoshikawa M, Oka M, et al. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 2001;288:827–832.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Shiozawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Oka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Soda</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic</ArticleTitle>
                  <JournalTitle>Int J Cancer.</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>146</FirstPage>
                  <LastPage>151</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14618629</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXps1entbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.11528</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shiozawa K, Oka M, Soda H, et al. Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.<Emphasis Type="Italic">Int J Cancer.</Emphasis> 2004;108:146–151.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rajendra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Gounder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Saleem</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>3228</FirstPage>
                  <LastPage>3233</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12810652</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXks1eiurc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rajendra R, Gounder MK, Saleem A, et al. Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2003;63:3228–3233.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Bates</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WY</Initials>
                    <FamilyName>Medina-Perez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kohlhagen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">ABCG2 mediates differential resistance to SN-38 and homocamptothecins</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>310</VolumeID>
                  <FirstPage>836</FirstPage>
                  <LastPage>842</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15075385</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtVykt7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.063149</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bates SE, Medina-Perez WY, Kohlhagen G, et al. ABCG2 mediates differential resistance to SN-38 and homocamptothecins.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2004;310:836–842.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Yoshikawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ikegami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hayasaka</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells</ArticleTitle>
                  <JournalTitle>Int J Cancer.</JournalTitle>
                  <VolumeID>110</VolumeID>
                  <FirstPage>921</FirstPage>
                  <LastPage>927</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15170677</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvFCmtLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.20216</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yoshikawa M, Ikegami Y, Hayasaka S, et al. Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells.<Emphasis Type="Italic">Int J Cancer.</Emphasis> 2004;110:921–927.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Honjo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Hrycyna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>QW</Initials>
                    <FamilyName>Yan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>6635</FirstPage>
                  <LastPage>6639</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11559526</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntFaisr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Honjo Y, Hrycyna CA, Yan QW, et al. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2001;61:6635–6639.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nakanishi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Karp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Tan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients</ArticleTitle>
                  <JournalTitle>Clin Cancer Res.</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>3320</FirstPage>
                  <LastPage>3328</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12960118</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXotFCksLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakanishi T, Karp JE, Tan M, et al. Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2003;9:3320–3328.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Volk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Farley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>5035</FirstPage>
                  <LastPage>5040</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12208758</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmslyksrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2002;62:5035–5040.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z-S</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Belinsky</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>4048</FirstPage>
                  <LastPage>4054</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12874005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlsFOju7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chen Z-S, Robey RW, Belinsky MG, et al. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2003;63:4048–4054.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Honjo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Morisaki</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity</ArticleTitle>
                  <JournalTitle>Br J Cancer.</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>1971</FirstPage>
                  <LastPage>1978</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14612912</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVers7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjc.6601370</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Robey RW, Honjo Y, Morisaki K, et al. Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.<Emphasis Type="Italic">Br J Cancer.</Emphasis> 2003;89:1971–1978.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Miwa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tsukahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Ishikawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Asada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Imai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugimoto</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants</ArticleTitle>
                  <JournalTitle>Int J Cancer.</JournalTitle>
                  <VolumeID>107</VolumeID>
                  <FirstPage>757</FirstPage>
                  <LastPage>763</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14566825</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVKjsrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.11484</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miwa M, Tsukahara S, Ishikawa E, Asada S, Imai Y, Sugimoto Y. Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.<Emphasis Type="Italic">Int J Cancer.</Emphasis> 2003;107:757–763.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Turnquist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Jackson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells</ArticleTitle>
                  <JournalTitle>Clin Cancer Res.</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>22</FirstPage>
                  <LastPage>28</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11801536</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhsVKmt74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kim M, Turnquist H, Jackson J, et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2002;8:22–28.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Scharenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Harkey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Torok-Storb</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>507</FirstPage>
                  <LastPage>512</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11781231</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmslGltw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood.V99.2.507</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.<Emphasis Type="Italic">Blood.</Emphasis> 2002;99:507–512.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugiyama</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">ABC G2 transports sulfated conjugates of steroids and xenobiotics</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>278</VolumeID>
                  <FirstPage>22644</FirstPage>
                  <LastPage>22649</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12682043</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXksF2it7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M212399200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. ABC G2 transports sulfated conjugates of steroids and xenobiotics.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2003;278:22644–22649.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Imai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Asada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tsukahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Ishikawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tsuruo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugimoto</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein exports sulfated estrogens but not free estrogens</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>610</FirstPage>
                  <LastPage>618</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12920197</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvFaiu7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.64.3.610</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;64:610–618.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Ifergan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Shafran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Jansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Hooijberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Scheffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YG</Initials>
                    <FamilyName>Assaraf</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: Aa role for BCRP in cellular folate homeostasis</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>279</VolumeID>
                  <FirstPage>25527</FirstPage>
                  <LastPage>25534</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15047700</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksFygsbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M401725200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL, Assaraf YG. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: Aa role for BCRP in cellular folate homeostasis.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2004;279:25527–25534.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Buitelaar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Wagenaar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>15449</FirstPage>
                  <LastPage>15654</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.202607599</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjvV2k</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jonker JW, Buitelaar M, Wagenaar E, et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:15449–15654.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Steadman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Polgar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1242</FirstPage>
                  <LastPage>1246</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14973080</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtleisb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-03-3298</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Robey RW, Steadman K, Polgar O, et al. Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2004;64:1242–1246.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Sinha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Gustafson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kulldorff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WQ</Initials>
                    <FamilyName>Wen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Cerhan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Zheng</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk</ArticleTitle>
                  <JournalTitle>J Natl Cancer Inst.</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>1352</FirstPage>
                  <LastPage>1354</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10944558</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmtlektrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/jnci/92.16.1352</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk.<Emphasis Type="Italic">J Natl Cancer Inst.</Emphasis> 2000:92:1352–1354.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Herwaarden</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Wagenaar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The breast cancer resistance protein (Berpl/Abeg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>6447</FirstPage>
                  <LastPage>6452</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14559835</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van Herwaarden AE, Jonker JW, Wagenaar E, et al. The breast cancer resistance protein (Berpl/Abeg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2003;63:6447–6452.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Woehlecke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Pohl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Alder-Baerens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lage</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Herrmann</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)</ArticleTitle>
                  <JournalTitle>Biochem J.</JournalTitle>
                  <VolumeID>376</VolumeID>
                  <FirstPage>489</FirstPage>
                  <LastPage>495</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12946267</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptFOqs74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/BJ20030886</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A. Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2).<Emphasis Type="Italic">Biochem J.</Emphasis> 2003;376:489–495.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Erlichman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Boerner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Hallgren</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The HER tyrosine kinase inhibitor C11033 enhances cytotoxicity of 7-ethyl-10-hydroxy-camptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>739</FirstPage>
                  <LastPage>748</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11212277</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXht1Gmt74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Erlichman C, Boerner SA, Hallgren CG, et al. The HER tyrosine kinase inhibitor C11033 enhances cytotoxicity of 7-ethyl-10-hydroxy-camptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2001;61:739–748.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Burger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Tol</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Boersma</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>104</VolumeID>
                  <FirstPage>2940</FirstPage>
                  <LastPage>2942</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15251980</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXpslKju7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2004-04-1398</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burger H, Van Tol H, Boersma AW, et al. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.<Emphasis Type="Italic">Blood.</Emphasis> 2004;104:2940–2942.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Imai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tsukahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Asada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugimoto</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>4346</FirstPage>
                  <LastPage>4352</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15205350</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvFWltr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-04-0078</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Imai Y, Tsukahara S, Asada S, Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2004;64:4346–4352.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Polli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Baughman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Humphreys</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The systemic exposure of an N-methyl-d-aspartate receptor antagonist is limited in mice by the p-glycoprotein and breast cancer resistance protein efflux transporters</ArticleTitle>
                  <JournalTitle>Drug Metab Dispos.</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>722</FirstPage>
                  <LastPage>726</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15205387</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXltlWqtL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/dmd.32.7.722</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Polli JW, Baughman TM, Humphreys JE, et al. The systemic exposure of an N-methyl-d-aspartate receptor antagonist is limited in mice by the p-glycoprotein and breast cancer resistance protein efflux transporters.<Emphasis Type="Italic">Drug Metab Dispos.</Emphasis> 2004;32:722–726.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Breedveld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Zelcer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Pluim</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mechanism of the pharmaco-kinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>5804</FirstPage>
                  <LastPage>5811</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15313923</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmslaksrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-03-4062</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Breedveld P, Zelcer N, Pluim D, et al. Mechanism of the pharmaco-kinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2004;64:5804–5811.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Furukawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nitanda</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>65</FirstPage>
                  <LastPage>72</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12488537</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjsVKi</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.63.1.65</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wang X, Furukawa T, Nitanda T, et al. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;63:65–72.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nitanda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Shi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol.</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <FirstPage>1363</FirstPage>
                  <LastPage>1370</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15345326</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntlemtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bcp.2004.05.052</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wang X, Nitanda T, Shi M, et al. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2004;68:1363–1370.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Brangi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ciotti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>5938</FirstPage>
                  <LastPage>5946</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10606239</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXht1SntQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brangi M, Litman T, Ciotti M, et al. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1999;59:5938–5946.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Rabindran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>He</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Singh</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>5850</FirstPage>
                  <LastPage>5858</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9865745</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXivFah</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rabindran SK, He H, Singh M, et al. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1998;58:5850–5858.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Sparreboom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Gelderblom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Marsh</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Diflomotecan pharmacokinetics in relation to ABC G2 421C&gt;A genotype</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther.</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>38</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15229462</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsVaqtrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.clpt.2004.03.003</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sparreboom A, Gelderblom H, Marsh S, et al. Diflomotecan pharmacokinetics in relation to ABC G2 421C&gt;A genotype.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 2004;76:38–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Volk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>5538</FirstPage>
                  <LastPage>5543</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14500392</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXntlersrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2003;63:5538–5543.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Nakagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Hara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Arakawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Nishimura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Komatani</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun.</JournalTitle>
                  <VolumeID>299</VolumeID>
                  <FirstPage>669</FirstPage>
                  <LastPage>675</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12459192</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XovFKkt7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-291X(02)02712-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakagawa R, Hara Y, Arakawa H, Nishimura S, Komatani H. ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 2002;299:669–675.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Komatani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kotani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Hara</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure</ArticleTitle>
                  <JournalTitle>Cancer Res.</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>2827</FirstPage>
                  <LastPage>2832</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11306452</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXivFGrurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Komatani H, Kotani H, Hara Y, et al. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.<Emphasis Type="Italic">Cancer Res.</Emphasis> 2001;61:2827–2832.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bruin</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Miyake</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Bates</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Reversal of resistance by GF120918 in cell lines expressing the ABC Half-transporter</ArticleTitle>
                  <JournalTitle>Cancer Lett.</JournalTitle>
                  <VolumeID>146</VolumeID>
                  <FirstPage>117</FirstPage>
                  <LastPage>126</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10656616</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3835(99)00182-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>de Bruin M, Miyake K, Litman T, Robey R, Bates SE. Reversal of resistance by GF120918 in cell lines expressing the ABC Half-transporter.<Emphasis Type="Italic">Cancer Lett.</Emphasis> 1999;146:117–126.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Loevezijn</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Lakhai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C</ArticleTitle>
                  <JournalTitle>Mol Cancer Ther.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>417</FirstPage>
                  <LastPage>425</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12477054</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjt1yqs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen JD, van Loevezijn A, Lakhai JM, et al. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.<Emphasis Type="Italic">Mol Cancer Ther.</Emphasis> 2002;1:417–425.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Loevezijn</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Schinkel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Koomen</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>32</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11140726</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(00)00588-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van Loevezijn A, Allen JD, Schinkel AH, Koomen GJ. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2001;11:29–32.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Özvegy-Laczka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Hegedus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Varady</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1485</FirstPage>
                  <LastPage>1495</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15155841</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.65.6.1485</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Özvegy-Laczka C, Hegedus T, Varady G, et al. High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2004;65:1485–1495.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Houghton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GS</Initials>
                    <FamilyName>Germain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FC</Initials>
                    <FamilyName>Harwood</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>2333</FirstPage>
                  <LastPage>2337</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15059881</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXis1yjt7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-03-3344</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Houghton PJ, Germain GS, Harwood FC, et al. Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2004;64:2333–2337.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CH</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YC</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Kuo</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantrone</ArticleTitle>
                  <JournalTitle>Anticancer Res</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>2519</FirstPage>
                  <LastPage>2523</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12894535</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmsFyrtbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yang CH, Chen YC, Kuo ML. Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantrone.<Emphasis Type="Italic">Anticancer Res</Emphasis>. 2003;23:2519–2523.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Sugimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tsukahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Imai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tsuruo</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists</ArticleTitle>
                  <JournalTitle>Mol Cancer Ther</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>105</FirstPage>
                  <LastPage>112</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12533678</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhtlOit7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sugimoto Y, Tsukahara S, Imai Y, Ueda K, Tsuruo T. Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.<Emphasis Type="Italic">Mol Cancer Ther</Emphasis>. 2003;2:105–112.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Schuetz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Bunting</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>1028</FirstPage>
                  <LastPage>1034</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11533706</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmvFOlsrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm0901-1028</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.<Emphasis Type="Italic">Nat Med</Emphasis>. 2001;7:1028–1034.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Minderman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>O'Loughlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Pendyala</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Baer</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein</ArticleTitle>
                  <JournalTitle>Clin Cancer Res</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1826</FirstPage>
                  <LastPage>1834</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15014037</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvFClt7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/1078-0432.CCR-0914-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Minderman H, O'Loughlin KL, Pendyala L, Baer MR. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2004;10:1826–1834.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Woehlecke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Osada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Herrmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lage</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A</ArticleTitle>
                  <JournalTitle>Int J Cancer</JournalTitle>
                  <VolumeID>107</VolumeID>
                  <FirstPage>721</FirstPage>
                  <LastPage>728</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14566821</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVKjsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.11444</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Woehlecke H, Osada H, Herrmann A, Lage H. Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A.<Emphasis Type="Italic">Int J Cancer</Emphasis>. 2003;107:721–728.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Morris</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1208</FirstPage>
                  <LastPage>1216</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15102949</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjsFKgtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.65.5.1208</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang S, Yang X, Morris ME. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2).<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1208–1216.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Cooray</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Janvilisri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HW</Initials>
                    <FamilyName>Veen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Hladky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Barrand</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Interaction of the breast cancer resistance protein with plant polyphenols</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>317</VolumeID>
                  <FirstPage>269</FirstPage>
                  <LastPage>275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15047179</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXisVKmtbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bbrc.2004.03.040</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2004;317:269–275.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gupta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Unadkat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">HiV Protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2)</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>310</VolumeID>
                  <FirstPage>334</FirstPage>
                  <LastPage>341</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15007102</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsVOjsbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.104.065342</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gupta A, Zhang Y, Unadkat JD, Mao Q. HiV Protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;310:334–341.</BibUnstructured>
              </Citation>
              <Citation ID="CR90">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Dort</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Buitelaar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Tellingen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Schinkel</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Mouse breast cancer resistance protein (Berpl/Abeg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>1339</FirstPage>
                  <LastPage>1344</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12649196</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXit1Sgtbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen JD, Van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH. Mouse breast cancer resistance protein (Berpl/Abeg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2003;63:1339–1344.</BibUnstructured>
              </Citation>
              <Citation ID="CR91">
                <CitationNumber>91.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Kruijtzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Beijnen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Rosing</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918</ArticleTitle>
                  <JournalTitle>J Clin Oncol</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>2943</FirstPage>
                  <LastPage>2950</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12089223</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlslyrt7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1200/JCO.2002.12.116</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kruijtzer CM, Beijnen JH, Rosing H, et al. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.<Emphasis Type="Italic">J Clin Oncol</Emphasis>. 2002;20:2943–2950.</BibUnstructured>
              </Citation>
              <Citation ID="CR92">
                <CitationNumber>92.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Smit</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RF</Initials>
                    <FamilyName>Brinkhuis</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan</ArticleTitle>
                  <JournalTitle>J Natl Cancer Inst.</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>1651</FirstPage>
                  <LastPage>1656</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11036110</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnvV2mtbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/jnci/92.20.1651</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.<Emphasis Type="Italic">J Natl Cancer Inst.</Emphasis> 2000;92:1651–1656.</BibUnstructured>
              </Citation>
              <Citation ID="CR93">
                <CitationNumber>93.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Jackson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Schinkel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A mutation hot spot in the Berpl (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>2294</FirstPage>
                  <LastPage>2299</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11956086</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjt1ejtbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen JD, Jackson SC, Schinkel AH. A mutation hot spot in the Berpl (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2002;62:2294–2299.</BibUnstructured>
              </Citation>
              <Citation ID="CR94">
                <CitationNumber>94.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Alqawi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bates</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Georges</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Arginine 482 to threonine 482 mutation in breast cancer resistance protein (ABCG2) inhibits rhodaminel 23 transport while increasing binding</ArticleTitle>
                  <JournalTitle>Biochem J</JournalTitle>
                  <VolumeID>382</VolumeID>
                  <FirstPage>711</FirstPage>
                  <LastPage>716</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15139851</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmvVOntLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/BJ20040355</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Alqawi O, Bates S, Georges E. Arginine 482 to threonine 482 mutation in breast cancer resistance protein (ABCG2) inhibits rhodaminel 23 transport while increasing binding.<Emphasis Type="Italic">Biochem J</Emphasis>. 2004;382:711–716.</BibUnstructured>
              </Citation>
              <Citation ID="CR95">
                <CitationNumber>95.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Zamber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>Lamba</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Yasuda</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine</ArticleTitle>
                  <JournalTitle>Pharmacogenetics</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>19</FirstPage>
                  <LastPage>28</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12544509</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlsFGrug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00008571-200301000-00004</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zamber CP, Lamba JK, Yasuda K, et al. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.<Emphasis Type="Italic">Pharmacogenetics</Emphasis>. 2003;13:19–28.</BibUnstructured>
              </Citation>
              <Citation ID="CR96">
                <CitationNumber>96.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Imai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nakane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kage</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance</ArticleTitle>
                  <JournalTitle>Mol Cancer ther</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>611</FirstPage>
                  <LastPage>616</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12479221</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsFSlsr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Imai Y, Nakane M, Kage K, et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.<Emphasis Type="Italic">Mol Cancer ther</Emphasis>. 2002;1:611–616.</BibUnstructured>
              </Citation>
              <Citation ID="CR97">
                <CitationNumber>97.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Honjo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Morisaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Huff</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)</ArticleTitle>
                  <JournalTitle>Cancer Biol Ther.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>696</FirstPage>
                  <LastPage>702</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12642696</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXntVSlt78%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.4161/cbt.322</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Honjo Y, Morisaki K, Huff LM. et al. Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).<Emphasis Type="Italic">Cancer Biol Ther.</Emphasis> 2002;1:696–702.</BibUnstructured>
              </Citation>
              <Citation ID="CR98">
                <CitationNumber>98.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mizuarai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Aozasa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kotani</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Single nucleotide polymorphisms result, in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2</ArticleTitle>
                  <JournalTitle>Int J Cancer</JournalTitle>
                  <VolumeID>109</VolumeID>
                  <FirstPage>238</FirstPage>
                  <LastPage>246</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14750175</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvVCksrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.11669</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mizuarai S, Aozasa N, Kotani H. Single nucleotide polymorphisms result, in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.<Emphasis Type="Italic">Int J Cancer</Emphasis>. 2004;109:238–246.</BibUnstructured>
              </Citation>
              <Citation ID="CR99">
                <CitationNumber>99.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kage</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tsukahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sugiyama</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization</ArticleTitle>
                  <JournalTitle>Int J Cancer</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>626</FirstPage>
                  <LastPage>630</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11807788</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XpsFWjtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.10100</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kage K, Tsukahara S, Sugiyama T, et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization.<Emphasis Type="Italic">Int J Cancer</Emphasis>, 2002;97:626–630.</BibUnstructured>
              </Citation>
              <Citation ID="CR100">
                <CitationNumber>100.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Jensen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1565</VolumeID>
                  <FirstPage>6</FirstPage>
                  <LastPage>16</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12225847</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmvVahtL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0005-2736(02)00492-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Litman T, Jensen U, Hansen A, et al. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 2002;1565:6–16.</BibUnstructured>
              </Citation>
              <Citation ID="CR101">
                <CitationNumber>101.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Conseil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gupta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Unadkat</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Functional expression of the human breast cancer resistance protein in Pichia pastoris</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>320</VolumeID>
                  <FirstPage>730</FirstPage>
                  <LastPage>737</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15240109</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsVaru7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bbrc.2004.06.012</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mao Q, Conseil G, Gupta A, Cole SP, Unadkat JD. Functional expression of the human breast cancer resistance protein in Pichia pastoris.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2004;320:730–737.</BibUnstructured>
              </Citation>
              <Citation ID="CR102">
                <CitationNumber>102.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Mitomo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Kato</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ito</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport</ArticleTitle>
                  <JournalTitle>Biochem J</JournalTitle>
                  <VolumeID>373</VolumeID>
                  <FirstPage>767</FirstPage>
                  <LastPage>774</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12741957</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlslOhurk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/BJ20030150</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mitomo H, Kato R, Ito A, et al. A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.<Emphasis Type="Italic">Biochem J</Emphasis>. 2003;373:767–774.</BibUnstructured>
              </Citation>
              <Citation ID="CR103">
                <CitationNumber>103.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Polgar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Robey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Morisaki</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mutational analysis of ABCG2: role of the GXXXG motif</ArticleTitle>
                  <JournalTitle>Biochemistry</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>9448</FirstPage>
                  <LastPage>9456</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15260487</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlt1yntr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/bi0497953</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Polgar O, Robey RW, Morisaki K, et al. Mutational analysis of ABCG2: role of the GXXXG motif.<Emphasis Type="Italic">Biochemistry</Emphasis>, 2004;43:9448–9456.</BibUnstructured>
              </Citation>
              <Citation ID="CR104">
                <CitationNumber>104.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ozvegy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Litman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Szakacs</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>285</VolumeID>
                  <FirstPage>111</FirstPage>
                  <LastPage>117</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11437380</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXkvVOluro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2001.5130</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ozvegy C, Litman T, Szakacs G, et al. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2001;285:111–117.</BibUnstructured>
              </Citation>
              <Citation ID="CR105">
                <CitationNumber>105.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Karp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TT</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Expression of breast cancer resistance protein in blast cells from patients with acute leukemia</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>365</FirstPage>
                  <LastPage>368</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10891476</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXksVKjtLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ross DD, Karp JE, Chen TT, Doyle LA. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia.<Emphasis Type="Italic">Blood</Emphasis>. 2000;96:365–368.</BibUnstructured>
              </Citation>
              <Citation ID="CR106">
                <CitationNumber>106.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Steinbach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Sell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Voigt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Zintl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Sauerbrey</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia</ArticleTitle>
                  <JournalTitle>Leukemia</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>1443</FirstPage>
                  <LastPage>1447</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12145683</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xls1Wqs7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.leu.2402541</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Steinbach D, Sell W, Voigt A, Hermann J, Zintl F, Sauerbrey A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.<Emphasis Type="Italic">Leukemia</Emphasis>, 2002;16:1443–1447.</BibUnstructured>
              </Citation>
              <Citation ID="CR107">
                <CitationNumber>107.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Plasschaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Kolk</FamilyName>
                    <Particle>Van Der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ES</Initials>
                    <FamilyName>Bont</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Vellenga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Kamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EG</Initials>
                    <FamilyName>Vries</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein (BCRP) in acute leukemia</ArticleTitle>
                  <JournalTitle>Leuk Lymphoma</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>649</FirstPage>
                  <LastPage>654</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15160935</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvV2lsbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/10428190310001597928</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Plasschaert SL, Van Der Kolk DM, De Bont ES, Vellenga E, Kamps WA, De Vries EG. Breast cancer resistance protein (BCRP) in acute leukemia.<Emphasis Type="Italic">Leuk Lymphoma</Emphasis>. 2004;45:649–654.</BibUnstructured>
              </Citation>
              <Citation ID="CR108">
                <CitationNumber>108.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Abbott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Colapietro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Barnes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Marini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Andreeff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BP</Initials>
                    <FamilyName>Sorrentino</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Low levels of ABCG2 expression in adult AML blast samples</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>4594</FirstPage>
                  <LastPage>4601</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12393637</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XpsFCqtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2002-01-0271</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Abbott BL, Colapietro AM, Barnes Y, Marini F, Andreeff M, Sorrentino BP. Low levels of ABCG2 expression in adult AML blast samples.<Emphasis Type="Italic">Blood</Emphasis>. 2002;100:4594–4601.</BibUnstructured>
              </Citation>
              <Citation ID="CR109">
                <CitationNumber>109.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Kolk</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Vellenga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Scheffer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>3763</FirstPage>
                  <LastPage>3770</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11986234</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood.V99.10.3763</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van der Kolk DM, Vellenga E, Scheffer GL, et al. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.<Emphasis Type="Italic">Blood</Emphasis>. 2002;99:3763–3770.</BibUnstructured>
              </Citation>
              <Citation ID="CR110">
                <CitationNumber>110.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Sauerbrey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Sell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Steinbach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Voigt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Zintl</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia</ArticleTitle>
                  <JournalTitle>Br J Haematol</JournalTitle>
                  <VolumeID>118</VolumeID>
                  <FirstPage>147</FirstPage>
                  <LastPage>150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12100141</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmtlWqsr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2141.2002.03550.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sauerbrey A, Sell W, Steinbach D, Voigt A, Zintl F. Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia.<Emphasis Type="Italic">Br J Haematol</Emphasis>. 2002;118:147–150.</BibUnstructured>
              </Citation>
              <Citation ID="CR111">
                <CitationNumber>111.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Plasschaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Kolk</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ES</Initials>
                    <FamilyName>Bont</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The role of breast cancer resistance protein in acute lymphoblastic leukemia</ArticleTitle>
                  <JournalTitle>Clin Cancer Res</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>5171</FirstPage>
                  <LastPage>5177</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14613996</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVOgurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Plasschaert SL, van der Kolk DM, de Bont ES, et al. The role of breast cancer resistance protein in acute lymphoblastic leukemia.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2003;9:5171–5177.</BibUnstructured>
              </Citation>
              <Citation ID="CR112">
                <CitationNumber>112.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Ren</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XY</Initials>
                    <FamilyName>Du</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XN</Initials>
                    <FamilyName>Guo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Relationship between resistance to chemotherapy and expression of breast cancer resistance protein (BCRP) gene in patients with acute leukemia</ArticleTitle>
                  <JournalTitle>Zhongguo Shi Yan Xue Ye Xue Za Zhi</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>55</FirstPage>
                  <LastPage>58</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14989769</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkt1aiu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ren JH, Du XY, Guo XN, et al. Relationship between resistance to chemotherapy and expression of breast cancer resistance protein (BCRP) gene in patients with acute leukemia.<Emphasis Type="Italic">Zhongguo Shi Yan Xue Ye Xue Za Zhi</Emphasis>. 2004;12:55–58.</BibUnstructured>
              </Citation>
              <Citation ID="CR113">
                <CitationNumber>113.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Pol</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Broxterman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Pater</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Function of the ABC transporters. P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia</ArticleTitle>
                  <JournalTitle>Haematologica</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>134</FirstPage>
                  <LastPage>147</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12604403</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van der Pol MA, Broxterman HJ, Pater JM, et al. Function of the ABC transporters. P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.<Emphasis Type="Italic">Haematologica</Emphasis>. 2003;88:134–147.</BibUnstructured>
              </Citation>
              <Citation ID="CR114">
                <CitationNumber>114.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Heuvel-Eibrink</FamilyName>
                    <Particle>van den</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Wiemer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Prins</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)</ArticleTitle>
                  <JournalTitle>Leukemia</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>833</FirstPage>
                  <LastPage>839</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11986944</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.leu.2402496</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XksFCktLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van den Heuvel-Eibrink MM, Wiemer EA, Prins A, et al. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).<Emphasis Type="Italic">Leukemia</Emphasis>. 2002;16:833–839.</BibUnstructured>
              </Citation>
              <Citation ID="CR115">
                <CitationNumber>115.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Sargent</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Williamson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Elgic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Scheper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Taylor</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia</ArticleTitle>
                  <JournalTitle>Br J Haematol</JournalTitle>
                  <VolumeID>115</VolumeID>
                  <FirstPage>257</FirstPage>
                  <LastPage>262</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11703319</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXptVyqsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2141.2001.03122.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sargent JM, Williamson CJ, Maliepaard M, Elgic AW, Scheper RJ, Taylor CG. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia.<Emphasis Type="Italic">Br J Haematol</Emphasis>. 2001;115:257–262.</BibUnstructured>
              </Citation>
              <Citation ID="CR116">
                <CitationNumber>116.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Stam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Heuvel-Eibrink</FamilyName>
                    <Particle>van den</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Boer</FamilyName>
                    <Particle>den</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein</ArticleTitle>
                  <JournalTitle>Leukemia</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>78</FirstPage>
                  <LastPage>83</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14574327</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvVektrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.leu.2403168</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stam RW, van den Heuvel-Eibrink MM, den Boer ML, et al. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.<Emphasis Type="Italic">Leukemia</Emphasis>. 2004;18:78–83.</BibUnstructured>
              </Citation>
              <Citation ID="CR117">
                <CitationNumber>117.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Suvannasankha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Minderman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>O'Loughlin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function</ArticleTitle>
                  <JournalTitle>Leukemia</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>1252</FirstPage>
                  <LastPage>1257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15208643</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvF2ku7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.leu.2403395</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Suvannasankha A, Minderman H, O'Loughlin KL, et al. Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.<Emphasis Type="Italic">Leukemia</Emphasis>. 2004;18:1252–1257.</BibUnstructured>
              </Citation>
              <Citation ID="CR118">
                <CitationNumber>118.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Scheffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Pijnenborg</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone-and topotecan-resistant cell lines</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>2589</FirstPage>
                  <LastPage>2593</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10825126</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsF2gt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Scheffer GL, Maliepaard M, Pijnenborg AC, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone-and topotecan-resistant cell lines.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2000;60:2589–2593.</BibUnstructured>
              </Citation>
              <Citation ID="CR119">
                <CitationNumber>119.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Diestra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Scheffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Catala</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material</ArticleTitle>
                  <JournalTitle>J Pathol</JournalTitle>
                  <VolumeID>198</VolumeID>
                  <FirstPage>213</FirstPage>
                  <LastPage>219</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12237881</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXivV2jsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/path.1203</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Diestra JE, Scheffer GL, Catala I, et al. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material.<Emphasis Type="Italic">J Pathol</Emphasis>. 2002;198:213–219.</BibUnstructured>
              </Citation>
              <Citation ID="CR120">
                <CitationNumber>120.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kawabata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Oka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Soda</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Expression and functional analyses of breast cancer resistance protein in lung cancer</ArticleTitle>
                  <JournalTitle>Clin Cancer Res.</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>3052</FirstPage>
                  <LastPage>3057</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12912956</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmtF2hs7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kawabata S, Oka M, Soda H, et al. Expression and functional analyses of breast cancer resistance protein in lung cancer.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2003;9:3052–3057.</BibUnstructured>
              </Citation>
              <Citation ID="CR121">
                <CitationNumber>121.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Yoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ishii</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yokose</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer</ArticleTitle>
                  <JournalTitle>Clin Cancer Res</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1691</FirstPage>
                  <LastPage>1697</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15014021</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvFCltr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/1078-0432.CCR-0937-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yoh K, Ishii G, Yokose T, et al. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2004;10:1691–1697.</BibUnstructured>
              </Citation>
              <Citation ID="CR122">
                <CitationNumber>122.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Candeil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Gourdier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Peyron</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases</ArticleTitle>
                  <JournalTitle>Int J Cancer</JournalTitle>
                  <VolumeID>109</VolumeID>
                  <FirstPage>848</FirstPage>
                  <LastPage>854</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15027118</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjt1ensrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ijc.20032</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Candeil L, Gourdier I, Peyron D, et al.: ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.<Emphasis Type="Italic">Int J Cancer</Emphasis>. 2004;109:848–854.</BibUnstructured>
              </Citation>
              <Citation ID="CR123">
                <CitationNumber>123.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kanzaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Toi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakayama</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Expression of multidrug resistance-related transporters in human breast carcinoma</ArticleTitle>
                  <JournalTitle>Jpn J Cancer Res</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>452</FirstPage>
                  <LastPage>458</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11346468</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXktFeksbg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1349-7006.2001.tb01115.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Kanzaki A, Toi M, Nakayama K, et al. Expression of multidrug resistance-related transporters in human breast carcinoma.<Emphasis Type="Italic">Jpn J Cancer Res</Emphasis>. 2001;92:452–458.</BibUnstructured>
              </Citation>
              <Citation ID="CR124">
                <CitationNumber>124.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IF</Initials>
                    <FamilyName>Faneyte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Kristel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maliepaard</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Expression of the breast cancer resistance protein in breast cancer</ArticleTitle>
                  <JournalTitle>Clin Cancer Res</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>1068</FirstPage>
                  <LastPage>1074</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11948115</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjsF2ltrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Faneyte IF, Kristel PM, Maliepaard M, et al. Expression of the breast cancer resistance protein in breast cancer.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2002;8:1068–1074.</BibUnstructured>
              </Citation>
              <Citation ID="CR125">
                <CitationNumber>125.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Burger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Foekens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Look</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response</ArticleTitle>
                  <JournalTitle>Clin Cancer Res</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>827</FirstPage>
                  <LastPage>836</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12576456</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhtVKksbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burger H, Foekens JA, Look MP, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2003;9:827–836.</BibUnstructured>
              </Citation>
              <Citation ID="CR126">
                <CitationNumber>126.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Morris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Barnes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Lan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Schuetz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BP</Initials>
                    <FamilyName>Sorrentino</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Berp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>12339</FirstPage>
                  <LastPage>12344</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12218177</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntlCksLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.192276999</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP. Berp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2002;99:12339–12344.</BibUnstructured>
              </Citation>
              <Citation ID="CR127">
                <CitationNumber>127.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tamaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Akatsuka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Ando</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle</ArticleTitle>
                  <JournalTitle>J Cell Biol</JournalTitle>
                  <VolumeID>157</VolumeID>
                  <FirstPage>571</FirstPage>
                  <LastPage>577</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11994315</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjslGlsLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1083/jcb.200112106</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tamaki T, Akatsuka A, Ando K, et al. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle.<Emphasis Type="Italic">J Cell Biol</Emphasis>. 2002;157:571–577.</BibUnstructured>
              </Citation>
              <Citation ID="CR128">
                <CitationNumber>128.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Leehner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Leech</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Abraham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Nolan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Habener</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Nestinpositive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>293</VolumeID>
                  <FirstPage>670</FirstPage>
                  <LastPage>674</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-291X(02)00275-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leehner A, Leech CA, Abraham EJ, Nolan AL, Habener JF. Nestinpositive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;293:670–674.</BibUnstructured>
              </Citation>
              <Citation ID="CR129">
                <CitationNumber>129.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Shimano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Satake</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Okaya</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>163</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12819005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmtVWrt7w%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0002-9440(10)63624-3</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Shimano K, Satake M, Okaya A, et al. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1.<Emphasis Type="Italic">Am J Pathol</Emphasis>. 2003;163:3–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR130">
                <CitationNumber>130.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AP</Initials>
                    <FamilyName>Meeson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Robertson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart</ArticleTitle>
                  <JournalTitle>Dev Biol</JournalTitle>
                  <VolumeID>265</VolumeID>
                  <FirstPage>262</FirstPage>
                  <LastPage>275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14697368</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhtVShsr3P</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ydbio.2003.09.028</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin CM, Meeson AP, Robertson SM, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart.<Emphasis Type="Italic">Dev Biol</Emphasis>. 2004;265:262–275.</BibUnstructured>
              </Citation>
              <Citation ID="CR131">
                <CitationNumber>131.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Krishnamurthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nakanishi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The stem cell marker Berp/ABCG2 enhances hypoxic cell survival through interactions with heme</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>279</VolumeID>
                  <FirstPage>24218</FirstPage>
                  <LastPage>24225</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15044468</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksV2isb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M313599200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Krishnamurthy P, Ross DD, Nakanishi T, et al., The stem cell marker Berp/ABCG2 enhances hypoxic cell survival through interactions with heme.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:24218–24225.</BibUnstructured>
              </Citation>
              <Citation ID="CR132">
                <CitationNumber>132.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Sarkadi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ozvegy-Laczka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nemet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Varadi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">ABCG2-a transporter for all seasons</ArticleTitle>
                  <JournalTitle>FEBS Lett</JournalTitle>
                  <VolumeID>567</VolumeID>
                  <FirstPage>116</FirstPage>
                  <LastPage>120</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15165903</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksVGht7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.febslet.2004.03.123</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sarkadi B, Ozvegy-Laczka C, Nemet K, Varadi A, ABCG2-a transporter for all seasons.<Emphasis Type="Italic">FEBS Lett</Emphasis>. 2004;567:116–120.</BibUnstructured>
              </Citation>
              <Citation ID="CR133">
                <CitationNumber>133.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Bunting</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">ABC transporters as phenotypic markers and functional regulators of stem cells</ArticleTitle>
                  <JournalTitle>Stem Cells</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>11</FirstPage>
                  <LastPage>20</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11796918</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhtlGktbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1634/stemcells.20-3-274</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells.<Emphasis Type="Italic">Stem Cells</Emphasis>. 2002;20:11–20.</BibUnstructured>
              </Citation>
              <Citation ID="CR134">
                <CitationNumber>134.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Abbott</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">ABCG2 (BCRP) expression in normal and malignant hematopoietic cells</ArticleTitle>
                  <JournalTitle>Hematol Oncol</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>115</FirstPage>
                  <LastPage>130</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14579240</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hon.714</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Abbott BL. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.<Emphasis Type="Italic">Hematol Oncol</Emphasis>. 2003;21:115–130.</BibUnstructured>
              </Citation>
              <Citation ID="CR135">
                <CitationNumber>135.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Taipalensuu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Tornblom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lindberg</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>299</VolumeID>
                  <FirstPage>164</FirstPage>
                  <LastPage>170</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11561076</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntFWlt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Taipalensuu J, Tornblom H, Lindberg G, et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;299:164–170.</BibUnstructured>
              </Citation>
              <Citation ID="CR136">
                <CitationNumber>136.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Cooray</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Blackmore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Maskell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Barrand</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Localisation of breast cancer resistance protein in microvessel endothelium of human brain</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>2059</FirstPage>
                  <LastPage>2063</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12438926</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XovVeiu78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200211150-00014</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cooray HC, Blackmore CG, Maskell L, Barrand MA. Localisation of breast cancer resistance protein in microvessel endothelium of human brain.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2002;13:2059–2063.</BibUnstructured>
              </Citation>
              <Citation ID="CR137">
                <CitationNumber>137.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mojsilovic-Petrovic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MF</Initials>
                    <FamilyName>Andrade</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ball</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Stanimirovic</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The expression and functional characterization of ABCG2 in brain endothelial cells and vessels</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>2085</FirstPage>
                  <LastPage>2087</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12958161</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1096/fj.02-1131fje</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels.<Emphasis Type="Italic">FASEB J</Emphasis>. 2003;17:2085–2087.</BibUnstructured>
              </Citation>
              <Citation ID="CR138">
                <CitationNumber>138.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Troger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Stotzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Martens-Lobenhoffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Gollnick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FP</Initials>
                    <FamilyName>Meyer</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Drug points: severe myalgia from an interaction between treatments with pantoprazole and methotrexate</ArticleTitle>
                  <JournalTitle>BMJ</JournalTitle>
                  <VolumeID>324</VolumeID>
                  <FirstPage>1497</FirstPage>
                  <LastPage>1497</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12077038</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD38zjtlKmtQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/bmj.324.7352.1497</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Troger U, Stotzel B, Martens-Lobenhoffer J, Gollnick H, Meyer FP. Drug points: severe myalgia from an interaction between treatments with pantoprazole and methotrexate.<Emphasis Type="Italic">BMJ</Emphasis>. 2002;324:1497.</BibUnstructured>
              </Citation>
              <Citation ID="CR139">
                <CitationNumber>139.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Mizuno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kusuhara</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice</ArticleTitle>
                  <JournalTitle>Drug Metab Dispos</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>898</FirstPage>
                  <LastPage>901</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15319327</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnsVegt7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mizuno N, Suzuki M, Kusuhara H, et al. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2004;32:898–901.</BibUnstructured>
              </Citation>
              <Citation ID="CR140">
                <CitationNumber>140.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Cisternino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mercier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Bourasset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Roux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Scherrmann</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Expression, up-regulation, and transport activity of the multidrug-resistance protein abcg2 at the mouse blood-brain barrier</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>3296</FirstPage>
                  <LastPage>3301</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15126373</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjs1ehtb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-03-2033</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann JM. Expression, up-regulation, and transport activity of the multidrug-resistance protein abcg2 at the mouse blood-brain barrier.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2004;64:3296–3301.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
